May 4 (Reuters) - Alk-abello A/S ALKb.CO :
* Co's house dust mite sublingual allergy immunotherapy tablet, Acarizax has been approved in Canada Source text for Eikon: ID:nGNXNURLKa Further company coverage: ALKb.CO
May 4 (Reuters) - Alk-abello A/S ALKb.CO :
* Co's house dust mite sublingual allergy immunotherapy tablet, Acarizax has been approved in Canada Source text for Eikon: ID:nGNXNURLKa Further company coverage: ALKb.CO